The most important reason for death from ovarian cancer is the late diagnosis of this
disease. The standard treatment of ovarian cancer includes surgery and chemotherapy …

Simple Summary This review significantly contributes to the research community by
providing insights into the role of serum-based biomarkers for the diagnosis of ovarian …

There remains a lack of effective and noninvasive methods for the diagnosis and prognosis
prediction of epithelial ovarian carcinoma (EOC). Here, we investigated the possibility of …

Objective Patients with ovarian cancer (OC) may develop anti‐Yo‐associated
paraneoplastic cerebellar degeneration (PCD)—a cerebellar ataxia associated with tumor …

Ovarian cancer is one of the gynaecology malignancies with the highest mortality rate.
Ovarian cancer stem cell (CSC) is a subpopulation of ovarian cancer cells with increased …

Resistance to olaparib is the major obstacle in targeted therapy for ovarian cancer (OC) with
poly (ADP-ribose) polymerase inhibitors (PARPis), prompting studies on novel combination …

Background: Ovarian cancer (OC) remains the deadliest gynecological malignancy, despite
significant treatment advances. The absence of early detection tests results in advanced …

Gynecological cancer is a term referring to malignancies that typically involve ovarian,
cervical, uterine, vaginal, and vulvar cancer. Combined, these cancers represent major …

Ovarian cancer is one of the most aggressive and significant malignant tumor forms in the
female reproductive system. It is the leading cause of death among gynecological cancers …

Liposarcoma is one of the most prevalent forms of soft tissue sarcoma, and its prognosis is
highly dependent on its molecular subtypes. Non-coding RNAs (ncRNAs) like microRNAs …